EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 199 filers reported holding EDITAS MEDICINE INC in Q1 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,430 | -5.2% | 1,850 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $15,229 | +13.5% | 1,850 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $13,414 | +688.1% | 1,850 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $1,702 | -99.9% | 1,850 | 0.0% | 0.00% | -33.3% |
Q3 2022 | $2,468,000 | -39.3% | 1,850 | -14.0% | 0.01% | -33.3% |
Q2 2022 | $4,067,000 | -0.3% | 2,150 | 0.0% | 0.01% | 0.0% |
Q1 2022 | $4,081,000 | -49.2% | 2,150 | 0.0% | 0.01% | -50.0% |
Q4 2021 | $8,033,000 | -0.4% | 2,150 | 0.0% | 0.02% | -5.3% |
Q3 2021 | $8,062,000 | -53.0% | 2,150 | -37.7% | 0.02% | -52.5% |
Q2 2021 | $17,170,000 | +34.8% | 3,450 | -5.5% | 0.04% | +17.6% |
Q1 2021 | $12,740,000 | -40.1% | 3,650 | -2.7% | 0.03% | -41.4% |
Q4 2020 | $21,274,000 | +7.9% | 3,750 | +7.1% | 0.06% | +544.4% |
Q3 2020 | $19,720,000 | -5.2% | 3,500 | -2.8% | 0.01% | -25.0% |
Q2 2020 | $20,791,000 | -80.5% | 3,600 | -75.5% | 0.01% | -83.6% |
Q1 2020 | $106,394,000 | – | 14,688 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |